Canada - English - Health Canada

lacombe drugs (1992) ltd - vitamin b1 (thiamine); vitamin b2 (riboflavin); nicotinamide; d-pantothenic acid (calcium d-pantothenate); vitamin b6 (pyridoxine hydrochloride); vitamin b12 (cyanocobalamin); biotin; ascorbic acid (ascorbic acid); vitamin d2 (ergocalciferol); dl-alpha tocopheryl acetate (vitamin e); folic acid; magnesium (magnesium sulfate); iron (ferrous sulfate); copper (copper gluconate); zinc (zinc sulfate); manganese (manganese sulfate); calcium (calcium carbonate); chromium (chromium chloride cr51); iodine (potassium iodide) - tablet (effervescent) - 9mg; 10mg; 40mg; 8mg; 3mg; 4mcg; 200mcg; 100mg; 200unit; 10unit; 0.4mg; 50mg; 4mg; 1mg; 2mg; 0.5mg; 125mg; 20mcg; 0.15mg - vitamin b1 (thiamine) 9mg; vitamin b2 (riboflavin) 10mg; nicotinamide 40mg; d-pantothenic acid (calcium d-pantothenate) 8mg; vitamin b6 (pyridoxine hydrochloride) 3mg; vitamin b12 (cyanocobalamin) 4mcg; biotin 200mcg; ascorbic acid (ascorbic acid) 100mg; vitamin d2 (ergocalciferol) 200unit; dl-alpha tocopheryl acetate (vitamin e) 10unit; folic acid 0.4mg; magnesium (magnesium sulfate) 50mg; iron (ferrous sulfate) 4mg; copper (copper gluconate) 1mg; zinc (zinc sulfate) 2mg; manganese (manganese sulfate) 0.5mg; calcium (calcium carbonate) 125mg; chromium (chromium chloride cr51) 20mcg; iodine (potassium iodide) 0.15mg - vitamins & minerals

Philippines - English - FDA (Food And Drug Administration)

pharma-surrey international, inc.; distributor: 46 bulusan st., sta. mesa heights, quezon city, metro manila - multivitamins - solution for intravenous infusion - retinol concentrate (vitamin a) cholecalciferol (vitamin d) alpha tocopheryl acetate (vitamin e) ascorbic acid (vitamin c) nicot

Ireland - English - HPRA (Health Products Regulatory Authority)

chem-pharm - vitamin a palmitate ; vitamin d3 ; nicotinamide; dexpanthenol; vitamin b12; vitamin e acetate ; thiamine hydrochloride ; riboflavin sodium phosphate ; pyridoxine - solution for injection - . - combinations of vitamins - cattle, pigs, sheep - vitamins and minerals

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

american health packaging - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.